THE EFFECT OF INCREASING BODY MASS INDEX ON CLINICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE TREATED WITH INFLIXIMAB.

(1) Gastroenterology, Leeds Institute Of Biomedical And Clinical Sciences, St James University Hopsital, Universityof Leeds, Leeds, United Kingdom

(2) Gastroenterology, St James University Hospital, Leeds Teaching Hospital Nhs Trust, Leeds, Leeds, United Kingdom



This item was part of UEG Week 2014

This item can be cited as: United European Gastroenterology Journal; 2014: 2 (Supplement 1)